J Linden Selected Research

J Linden Research Topics

Disease

8	Ischemia 12/2001 - 04/2000
5	Inflammation (Inflammations) 05/2009 - 01/2001
4	Reperfusion Injury 09/2006 - 08/2001
2	Colitis 08/2018 - 09/2008
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2010 - 09/2006
2	Spinal Cord Ischemia 10/2001 - 09/2001
1	Human Influenza (Influenza) 05/2019
1	Gastritis 05/2009
1	Infections 05/2009
1	Hyperplasia 09/2008
1	Weight Loss (Weight Reduction) 09/2008
1	Demyelinating Diseases (Demyelinating Disease) 09/2006
1	Spinal Cord Compression 09/2006
1	Endotoxemia 08/2006
1	Hypoxia (Hypoxemia) 06/2006
1	Enteritis 05/2006
1	Diarrhea 05/2006
1	Pseudomembranous Enterocolitis (Pseudomembranous Colitis) 05/2006
1	Edema (Dropsy) 05/2006
1	Coronary Stenosis (Coronary Artery Stenosis) 09/2001
1	Hypotension (Low Blood Pressure) 09/2001
1	Paralysis (Palsy) 09/2001
1	Necrosis 07/2001
1	Pressure Ulcer (Bedsore) 07/2001
1	Vascular System Injuries 05/2001
1	Hemorrhage 03/2001
1	Hemophilia A (Haemophilia) 03/2001
1	Leukemia 01/2001
1	Ganglion Cysts (Ganglion) 07/2000
1	Stomach Diseases 01/2000

Drug/Important Bio-Agent (IBA)

11	Adenosine (Adenocard)FDA LinkGeneric 05/2009 - 04/2000
6	Purinergic P1 Receptors (Adenosine Receptor)IBA 05/2009 - 11/2000
6	ATL 146eIBA 10/2001 - 06/2001
4	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2010 - 05/2001
3	EstersIBA 01/2010 - 10/2001
3	furanIBA 01/2010 - 10/2001
3	ATL 313IBA 01/2010 - 05/2006
2	Dextrans (Dextran)FDA Link 08/2018 - 09/2008
2	piperidineIBA 01/2010 - 09/2006
2	Carboxylic AcidsIBA 01/2010 - 09/2006
2	Proteins (Proteins, Gene)FDA Link 09/2008 - 07/2000
2	Messenger RNA (mRNA)IBA 09/2008 - 07/2000
2	Peroxidase (Myeloperoxidase)IBA 05/2006 - 06/2001
2	Inosine FDA Link 01/2001 - 04/2000
1	VaccinesIBA 05/2019
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 08/2018
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 08/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2018
1	Interleukin-1beta (Interleukin 1 beta)IBA 08/2018
1	Enalapril FDA LinkGeneric 08/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2018
1	Dextran SulfateIBA 08/2018
1	Angiotensin Receptor AntagonistsIBA 08/2018
1	Losartan (Cozaar)FDA LinkGeneric 08/2018
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 08/2018
1	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 01/2010
1	P-2 (P 2)IBA 01/2010
1	Adenosine A2 Receptor AgonistsIBA 01/2010
1	CytokinesIBA 05/2009
1	Adenosine A2B ReceptorIBA 09/2008
1	Piroxicam (Feldene)FDA LinkGeneric 09/2008
1	SodiumIBA 09/2008
1	Interleukin-6 (Interleukin 6)IBA 09/2008
1	Phenol (Carbolic Acid)FDA Link 09/2006
1	Clostridium difficile tcdA proteinIBA 05/2006
1	Adenosine DeaminaseIBA 05/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2006
1	Purinergic P1 Receptor AntagonistsIBA 10/2001
1	BW A1433IBA 10/2001
1	cyclohexanecarboxylic acidIBA 10/2001
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 09/2001
1	MetalsIBA 07/2001
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2001
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 06/2001
1	RolipramIBA 06/2001
1	CreatinineIBA 06/2001
1	Phosphodiesterase 4 InhibitorsIBA 06/2001
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2001
1	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 01/2001

Therapy/Procedure

2	Therapeutics 03/2001 - 01/2000
1	Laminectomy 01/2010
1	Ligation 05/2001